🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Advanced Biomed Inc. (ADVB)
NASDAQ: ADVB · Real-Time Price · USD
1.650
-0.100 (-5.71%)
At close: Nov 20, 2026, 4:00 PM EST
1.660
+0.010 (0.61%)
After-hours: Nov 20, 2026, 5:57 PM EST

Advanced Biomed Income Statement

Millions USD. Fiscal year is Jul - Jun.
Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
0.130.13----
Revenue Growth
------
Gross Profit
0.130.13----
Selling, General & Admin
5.454.631.091.661.690.75
Research & Development
---0.881.381.62
Operating Expenses
7.196.361.092.543.072.37
Operating Income
-7.06-6.23-1.09-2.54-3.07-2.37
Interest Expense
-0.02-0.01----
Interest & Investment Income
---0.050.020
Currency Exchange Gain (Loss)
----0.29-0.51-
Other Non Operating Income (Expenses)
-0.02-0.02-0-0.02-0.04
EBT Excluding Unusual Items
-7.1-6.26-1.09-2.78-3.58-2.41
Impairment of Goodwill
------1.62
Gain (Loss) on Sale of Assets
-----0.15-
Pretax Income
-7.1-6.26-1.09-2.78-3.73-4.03
Income Tax Expense
-0-0----
Earnings From Continuing Operations
-7.1-6.26-1.09-2.78-3.73-4.03
Earnings From Discontinued Operations
13.1812.94-2.17---
Net Income
6.076.68-3.26-2.78-3.73-4.03
Net Income to Common
6.076.68-3.26-2.78-3.73-4.03
Net Income Growth
------
Shares Outstanding (Basic)
111111
Shares Outstanding (Diluted)
111111
Shares Change
33.29%22.06%2.63%0.32%40.55%23.74%
EPS (Basic)
4.355.33-3.18-2.78-3.74-5.68
EPS (Diluted)
4.355.33-3.18-2.78-3.74-5.68
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Free Cash Flow
-1.51-1.95-5.83-2.2-3.17-1.63
Free Cash Flow Per Share
-1.08-1.55-5.68-2.20-3.19-2.30
Gross Margin
100.00%100.00%----
Operating Margin
-5531.56%-4883.81%----
Profit Margin
4759.53%5231.30%----
Free Cash Flow Margin
-1181.53%-1525.38%----
EBITDA
--6.17-0.74-2.14-2.84-2.26
D&A For EBITDA
-0.060.340.40.230.11
EBIT
-7.06-6.23-1.09-2.54-3.07-2.37
SEC Filings: 10-K · 10-Q